Exploring a new therapy for adolescents with PTSD
Clinical and Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry in Adolescent With Posttraumatic Stress Disorder
This study is testing a new therapy called Reminder Focused Positive Psychiatry to see if it can help teenagers aged 11-15 with PTSD feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 11 Years to 15 Years |
| Sex | All |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT04529031 on ClinicalTrials.gov |
What this trial studies
This study evaluates the clinical and biomolecular characteristics of Reminder Focused Positive Psychiatry (RFPP) in adolescents aged 11-15 years who have been diagnosed with posttraumatic stress disorder (PTSD). The research will involve recruiting 60 eligible adolescents from the Olive View UCLA Pediatrics Clinics, where they will be randomized into either the RFPP intervention group or an attentional control condition. The aim is to assess the feasibility and effectiveness of RFPP in improving PTSD symptoms and vascular function. Parental consent and adolescent assent will be obtained prior to participation.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 11-15 years with a documented diagnosis of PTSD who can read and write in English.
Not a fit: Patients with intellectual disabilities, psychotic behaviors, or other specified neurodevelopmental disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve PTSD symptoms and overall mental health in adolescents.
How similar studies have performed: While RFPP is a novel approach, similar interventions have shown promise in improving PTSD symptoms in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Boy/Girl with documented PTSD, * aged 11- 15 years old, * able to read/write in English Exclusion Criteria: * presence of intellectual disabilities, * presence of psychotic or self-injurious behavior, * presence of seizure disorder, * presence of language disorder, * presence of eye disorders, * presence of other neurodevelopmental disorders, * presence of diagnosis of substance use disorder.
Where this trial is running
Los Angeles, California
- UCLA — Los Angeles, California, United States (Recruiting)
Study contacts
- Study coordinator: Naser Ahmadi, MD PhD
- Email: ahmadi@ucla.edu
- Phone: 424 298 8846
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.